Marked lymphovascular invasion, progesterone receptor negativity, and high Ki67 labeling index predict poor outcome in breast cancer patients treated with endocrine therapy alone. (Q43935330)

From Wikidata

Jump to navigation Jump to search

scientific article published on 12 June 2012

Language	Label	Description	Also known as
English	Marked lymphovascular invasion, progesterone receptor negativity, and high Ki67 labeling index predict poor outcome in breast cancer patients treated with endocrine therapy alone.	scientific article published on 12 June 2012

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22689016%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Marked lymphovascular invasion, progesterone receptor negativity, and high Ki67 labeling index predict poor outcome in breast cancer patients treated with endocrine therapy alone (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22689016%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22689016%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

8

object named as

Hitoshi Tsuda

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22689016%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Chikako Shimizu

7

object named as

Chikako Shimizu

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22689016%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

author name string

Junichi Kurebayashi

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22689016%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Toshiro Shimo

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22689016%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Tetsumasa Yamashita

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22689016%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Kenjiro Aogi

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22689016%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Rieko Nishimura

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22689016%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Takuya Moriya

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22689016%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Hiroshi Sonoo

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22689016%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

publication date

12 June 2012

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22689016%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22689016%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

21

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22689016%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22689016%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

214-222

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22689016%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

https://scigraph.springernature.com/pub.10.1007/s12282-012-0380-z

0 references

Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0380-Z

21 January 2018

Adjuvant chemotherapy in luminal breast cancers.

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0380-Z

21 January 2018

Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0380-Z

21 January 2018

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0380-Z

21 January 2018

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0380-Z

21 January 2018

Insulin-like growth factor-1 receptor gene expression is associated with survival in breast cancer: a comprehensive analysis of gene copy number, mRNA and protein expression.

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0380-Z

21 January 2018

Aldehyde dehydrogenase 1 expression predicts poor prognosis in triple-negative breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0380-Z

21 January 2018

Prognosis and management of patients with node-negative invasive breast carcinoma that is 1 cm or smaller in size (stage 1; T1a,bN0M0): a review of the literature

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0380-Z

21 January 2018

Objective assessment of lymphatic and blood vascular invasion in lymph node-negative breast carcinoma: findings from a large case series with long-term follow-up.

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0380-Z

21 January 2018

Progesterone Receptor Status Significantly Improves Outcome Prediction Over Estrogen Receptor Status Alone for Adjuvant Endocrine Therapy in Two Large Breast Cancer Databases

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0380-Z

21 January 2018

Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0380-Z

21 January 2018

Clinical value of epidermal growth factor receptor expression in primary breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0380-Z

21 January 2018

Possible treatment strategies for triple-negative breast cancer on the basis of molecular characteristics

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0380-Z

21 January 2018

Prognostic markers in triple-negative breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0380-Z

21 January 2018

Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0380-Z

21 January 2018

Invasive ductal carcinoma of the breast with the "triple-negative" phenotype: prognostic implications of EGFR immunoreactivity

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0380-Z

21 January 2018

Insulin-like growth factors in human breast cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0380-Z

21 January 2018

Mechanisms of disease: understanding resistance to HER2-targeted therapy in human breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0380-Z

21 January 2018

A kinome-wide screen identifies the insulin/IGF-I receptor pathway as a mechanism of escape from hormone dependence in breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0380-Z

21 January 2018

Insulin and insulin-like growth factor signalling in neoplasia

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0380-Z

21 January 2018

ALDH1 as a functional marker of cancer stem and progenitor cells

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0380-Z

21 January 2018

Heterogeneity for stem cell-related markers according to tumor subtype and histologic stage in breast cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0380-Z

21 January 2018

Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0380-Z

21 January 2018

Targeting breast cancer stem cells

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0380-Z

21 January 2018

Identifiers

10.1007/S12282-012-0380-Z

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22689016%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

release_ucqfzdbvhnek3omuk4yr43g2me

1 reference

https://api.fatcat.wiki/v0/release/ucqfzdbvhnek3omuk4yr43g2me

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22689016%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43935330&oldid=2104499077"